The Largest Companies in In Vitro & In Vivo Diagnostic Substances Industry
Explore the largest companies by market capitalization, revenue, income, and employees within the In Vitro & In Vivo Diagnostic Substances industry
Explore the largest companies by market capitalization, revenue, income, and employees within the In Vitro & In Vivo Diagnostic Substances industry
| Company | Market Cap (Millions) |
Revenue TTM (Millions) |
Net Income TTM (Millions) |
|---|---|---|---|
| Idexx Laboratories Inc | $ 41,184 | $ 4,554 | $ 1,140 |
| Lantheus Holdings Inc | $ 6,734 | $ 1,555 | $ 275 |
| Neogen Corporation | $ 2,993 | $ 870 | $ -8 |
| Celldex Therapeutics inc | $ 2,421 | $ 6 | $ -301 |
| Intellia Therapeutics Inc | $ 1,568 | $ 60 | $ -400 |
| Total In Vitro & In Vivo Diagnostic Substances Industry | $ 57,536 | $ 10,659 | $ -746 |
Sign in to unlock the full In Vitro & In Vivo Diagnostic Substances Industry dataset.
Industry Benchmarking Dataset for Institutional Use
CommercialThe data presented above is part of our institutional-grade Industry Benchmarking Dataset, designed for integration into credit risk models, AML/KYC frameworks, portfolio analytics, and internal banking systems. The full dataset is available under a Commercial License, with delivery via API or bulk CSV datasets.
Margin benchmarks across the full industry distribution
Gross, operating, EBITDA, pre-tax, net, and free cash flow margins - delivered as TTM, quarterly, and annual series with P25 / median / P75 / standard deviation for every reporting period.
Revenue, income & cash flow growth across 13+ line items
Industry-level growth benchmarks for every major P&L and cash flow line - with breadth indicators showing what share of companies posted positive growth, acceleration metrics, and rolling TTM comparisons.
Industry valuation multiples with 5-year context & Z-scores
P/E, P/S, P/FCF, P/Book, EV/EBITDA - current and trailing - with five-year averages, percentile ranks, Z-scores, and a composite valuation score to place the industry in historical context.
Productivity, turnover ratios & cash conversion benchmarks
Revenue and income per employee, asset and receivables turnover, days sales outstanding, days inventory, days payables, and the full cash conversion cycle - benchmarked across the industry distribution.
ROA, ROE, ROIC & DuPont decomposition benchmarks
Return metrics measuring how effectively management allocates capital - with incremental ROIC, DuPont decomposition, FCF quality indicators, and a composite management effectiveness score across the industry.
Leverage, liquidity & debt coverage across the industry
Debt-to-equity, interest and debt coverage, quick ratio, working capital, leverage ratios - full distribution statistics - in standardized, audit-ready format suited for credit workflows, compliance, and ESG reporting.
Recent News from The Largest Companies in In Vitro & In Vivo Diagnostic Substances Industry
Decision Framework & Data Access
Power onboarding, benchmarking, and quantitative analysis with institutional-grade datasets structured for direct integration into financial models and risk frameworks.
- Industry benchmarking datasets (valuation, growth, profitability)
- Designed for quant models, AML/KYC validation & onboarding workflows
- Consistent time-series structure (Quarterly, TTM, Annual)
- Coverage across 100+ industries and 20+ years of history